Received: 23 July 2020
Accepted: 5 October 2020
First Online: 15 October 2020
Ethics approval and consent to participate
: For BaroTest survey, consent was obtained using a written informed consent. The research protocol was validated by the Committee for the protection of the persons (CPP), the French ethical committee for biomedical research (no. 2015-A01252–47).Data from the SNDS used in this work received approval from the French data protection authority (CNIL: Commission nationale de l’informatique et des libertés) in October 2001. A ministerial order dated 1st December 2011 gave to accredited staff of the national public health agency access to SNDS anonymized individual data. The authors, who did the extraction and analysis, were accredited to SNDS database access.Modelling methods used data that were previously published.
: Not applicable.
: Stéphane Chevaliez has received research grants from Gilead and has served as an advisor and/or speaker for Abbott, Cepheid, Hologic.Victor de Lédinghen has received consulting fees from Gilead, AbbVie.Christine Silvain has served as a speaker for AbbVie, Gilead.All these grants and fees were independent of the work presented in this article.None for the other authors.